ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

TPI1 activates the PI3K/AKT/mTOR signaling pathway to induce breast cancer progression by stabilizing CDCA5

Jin, Xiaoying; Wang, Dandan; Lei, Mengxia; Guo, Yan; Cui, Yuqing; Chen, Fengzhi; Sun, Weiling*; Chen, Xuesong*哈尔滨医科大学
Journal of Translational Medicine2022-5-4DOI: 10.1186/s12967-022-03370-2
16被引7阅读
引用收藏
分享

摘要

Background Triosephosphate isomerase 1 (TPI1), as a key glycolytic enzyme, is upregulated in multiple cancers. However, expression profile and regulatory mechanism of TPI1 in breast cancer (BRCA) remain mysterious. Methods Western blotting and immunohistochemistry (IHC) assays were used to investigate the expression of TPI1 in BRCA specimens and cell lines. TPI1 correlation with the clinicopathological characteristics and prognosis of 362 BRCA patients was analyzed using a tissue microarray. Overexpression and knockdown function experiments in cells and mice models were performed to elucidate the function and mechanisms of TPI1-induced BRCA progression. Related molecular mechanisms were clarified using co-IP, IF, mass spectrometric analysis, and ubiquitination assay. Results We have found TPI1 is highly expressed in BRCA tissue and cell lines, acting as an independent indicator for prognosis in BRCA patients. TPI1 promotes BRCA cell glycolysis, proliferation and metastasis in vitro and in vivo. Mechanistically, TPI1 activates phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway to regulate epithelial-mesenchymal transformation (EMT) and aerobic glycolysis, which is positively mediated by cell division cycle associated 5 (CDCA5). Moreover, TPI1 interacts with sequestosome-1 (SQSTM1)/P62, and P62 decreases the protein expression of TPI1 by promoting its ubiquitination in MDA-MB-231 cells. Conclusions TPI1 promotes BRCA progression by stabilizing CDCA5, which then activates the PI3K/AKT/mTOR pathway. P62 promotes ubiquitin-dependent proteasome degradation of TPI1. Collectively, TPI1 promotes tumor development and progression, which may serve as a therapeutic target for BRCA.

学科与关键词

关键词
TPI1CDCA5GlycolysisEpithelial-mesenchymal transformation (EMT)PI3KAKTmTOR
相关
加载中…
  • USF1-ATRAP-PBX3 Axis Promote Breast Cancer Glycolysis and Malignant Phenotype by Activating AKT/mTOR Signaling
    Wang, Dandan; Jin, Xiaoying; Lei, Mengxia; Jiang, Ying; Liu, Yali; Yu, Fei; Guo, Yan; Han, Bing; Yang, Yue; Sun, Weiling; Liu, Ying; Zeng, Guangchun; Liu, Feng*; Hu, Jing*; Chen, Xuesong*International Journal of Biological Sciences, 2022, 18(6): 2452-2471.被引 6
  • Tetraspanin 1 (TSPAN1) promotes growth and transferation of breast cancer cells via mediating PI3K/Akt pathway
    Wu, Yange*; Chen, Wenxiu; Gong, Yufeng; Liu, Hongxia; Zhang, BoBioengineered, 2021, 12(2): 10761-10770.被引 12
  • AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway
    Qu, Jiayao; Li, Jia; Zhang, Yaming; He, Rongzhang; Liu, Xiangting; Gong, Ke; Duan, Lili; Luo, Weihao; Hu, Zheng; Wang, Gengsheng; Xia, Chenglai*; Luo, Dixian*Cell and Bioscience, 2021, 11(1): 163.被引 32
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Translational Medicine
发表日期
2022-05-04
卷期
第 20 卷, 第 1 期
页码
191
DOI
10.1186/s12967-022-03370-2
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation Grant of China [81773295, 81573001]; Harbin Medical University Scientific Research and Innovation Project Fund [YJSCX2020-48HYD]; Haiyan Research Fund Project of Harbin Medical University Cancer Hospital [JJQN2019-09]

作者

  • J

    Jin, Xiaoying (第一作者)

    harbin med univ

  • W

    Wang, Dandan

    harbin med univ

查看全部 8 位作者收起作者
  • L

    Lei, Mengxia

    harbin med univ

  • G

    Guo, Yan

    harbin med univ

  • C

    Cui, Yuqing

    harbin med univ

  • C

    Chen, Fengzhi

    harbin med univ

  • S

    Sun, Weiling (通讯)

    harbin med univ

  • C

    Chen, Xuesong (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417